Literature DB >> 6498266

Mass-action formulations of monovalent and divalent cation adsorption by phospholipid membranes.

J A Cohen, M Cohen.   

Abstract

An extension of a previous treatment (Cohen, J. A., and M. Cohen, 1981, Biophys. J., 36:623-651) is presented for the adsorption of monovalent and divalent cations by single-component phospholipid membranes, where monovalent cations adsorb with a cation/phospholipid stoichiometry of 1:1 and divalent cations adsorb with stoichiometries of 1:1 and 1:2. Previously the 1:1 and 1:2 binding of divalent cations were assumed to occur by independent, parallel pathways. Here a serial adsorption scheme is considered in which 1:2 binding occurs via reaction of 1:1-bound complexes with adjacent unoccupied phospholipids. This two-dimensional lattice reaction is shown to obey a law of mass action, and the mass-action equilibrium constant is used to parameterize the adsorption isotherm. This isotherm is shown to be mathematically equivalent to the previous isotherm, although the two formulations differ in the dependence of 1:2 binding on the 1:1 association constant.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6498266      PMCID: PMC1435011          DOI: 10.1016/S0006-3495(84)84045-X

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  1 in total

1.  Adsorption of monovalent and divalent cations by phospholipid membranes. The monomer-dimer problem.

Authors:  J A Cohen; M Cohen
Journal:  Biophys J       Date:  1981-12       Impact factor: 4.033

  1 in total
  2 in total

Review 1.  Counterion-mediated cluster formation by polyphosphoinositides.

Authors:  Yu-Hsiu Wang; David R Slochower; Paul A Janmey
Journal:  Chem Phys Lipids       Date:  2014-01-15       Impact factor: 3.329

2.  Binding of peptides with basic residues to membranes containing acidic phospholipids.

Authors:  J Kim; M Mosior; L A Chung; H Wu; S McLaughlin
Journal:  Biophys J       Date:  1991-07       Impact factor: 4.033

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.